Lead Coordinator

 

Professor Hakan Erdem, M.D.WhatsApp Image 2020-05-03 at 19.12.03

Infect. Dis. & Clin. Microbiol.

Consultant, Lecturer

ID-IRI Lead Coordinator

ESCMID Fellow

Ankara, Türkiye

 

EXECUTIVE PROFILE

I was born in 1969 in Turkey. I became a general practitioner after graduation from GATA medical faculty in 1993 and worked as a general practitioner between 1994 and 1996. I have performed my “Infectious Diseases and Clinical Microbiology” fellowship in GATA Haydarpasa Training Hospital in Istanbul during 1996-2000. I worked as sn infectious diseases specialist in Sivas Hospital in 2000-2003. I became an assistant professor in Gulhane Medical Academy in 2003, and an associate professor in 2006. I worked as the chief of Infectious Diseases and Clinical Microbiology Department in GATA Haydarpasa Hospital in Istanbul between July 2014 and July 2015. I became a Full Professor in June 2015. Subsequently, I worked in the field in several hospitals and currently, I am working for the ministry.

 

SKILL HIGHLIGHTS

  • Clinical teacher, lecturer
  • An experienced clinician in the field of infectious diseases
    • Experience in ICU infections
    • Experience in community-acquired infections
  • Multinational/multicenter clinical research management
  • Experience in scientific activities of European Society for Clinical Microbiology and Infectious Diseases (ESCMID) and other societies
    • Active memberships in ESGIB, ESGITM, ESGCIP

 

PROFESSIONAL EXPERIENCE

I worked in the field of infectious diseases and clinical microbiology since 1996 and performed many clinical pieces of research since then. I have founded ID-IRI, an international research platform in 2008. We have performed many multicentric/multinational projects through ID-IRI since then.

INTERNATIONAL AWARDS

On April 24, 2017, I was awarded the merit-based “ESCMID Fellow” title by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) executive committee. This title recognizes individuals who have achieved professional excellence and rendered outstanding service to the profession and the society.

 

PUBLICATIONS

INTERNATIONAL ID TEXTBOOK SECTIONS

  1. Gul HC, Erdem H. Brucellosis (Brucella species). In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglass, and Bennett’s Principles and Practice of Infectious Diseases. 9th Philadelphia: Elsevier Co; 2020: 2753-59
  2. Beeching N, Erdem H. Brucellosis In: Cohen J, Day J, eds. Cohen’s Textbook of Infectious Diseases Section 6, Chapter 129, 2016: 1098-1101
  3. Gul HC, Erdem H. Brucellosis (Brucella species). In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglass, and Bennett’s Principles and Practice of Infectious Diseases. 8 ed. Philadelphia: Elsevier Co; 2015: 2584-9.
  4. Coskun O, Erdem H. Urinary tract infections. In: Isik AT, Mas RT, Karan MA, Grossberg GT, eds. New horizons in geriatric medicine. New York: Nova Science Publishers 2013; 291-306.
  5. Kartal E, Erdem H. Sepsis and bacteremia, meningitis, influenza infection, infectious diarrhea. In: Shrader AL. Meningitis, symptoms, management and potential complications. New York: Nova Science Publishers, 2014:109-22.

 

EDITING INTERNATIONAL ID TEXTBOOKS

  1. Extrapulmonary Tuberculosis. Alper Sener, Hakan Erdem editors. Springer Co, Switzerland. 2019. ISBN 978-3-030-04743-6; ISBN 978-3-030-04744-3 (eBook); https://doi.org/10.1007/978-3-030-04744-3

 

ORIGINAL (MAJOR) ARTICLES PUBLISHED IN INTERNATIONAL JOURNALS

  1. Oncul O, Erdem H, Altunay H, Ozsoy M, Pahsa A, Cavuslu S. The Trends Of Penicillin Resistant Streptococcus Pneumoniae In A Training Hospital. Internet J Infect Dis 2002; 3: 1–6.
  2. Ormeci N, Soykan I, Palabiyikoglu M, et al. A new therapeutic approach for treatment of hydatid cysts of the spleen. Dig Dis Sci 2002; 47: 2037–44.
  3. Erdem H, Kilic S, Cinar E, Pahsa A. Symptomatic Intestinal Amoebiasis and Climatic Parameters. Scand J Infect Dis 2003; 35: 186–8.
  4. Erdem H, Cetin M, Timuroglu T, Cetin A, Yanar O, Pahsa A. Identification of yeasts in public hospital primary care patients with or without clinical vaginitis. Aust New Zeal J Obstet Gynaecol 2003; 43. DOI:10.1046/j.0004-8666.2003.00089.x.
  5. Yildirim A, Oh C, Erdem H, Kunt T. Bacteriology in patients with chronic sinusitis who have been medically and surgically treated. Ear, Nose Throat J 2004; 83: 836–8.
  6. Yildirim A, Erdem H, Kilic S, Yetiser S, Pahsa A. Effect of climate on the bacteriology of chronic suppurative otitis media. Ann Otol Rhinol Laryngol 2005; 114: 652–5.
  7. Ormeci N, Idilman R, Tuzun A, Erdem H, Palabiyikoglu M. A new percutaneous approach for the treatment of hydatid cyst of the kidney: Long-term follow-up. Int Urol Nephrol 2005; 37. DOI:10.1007/s11255-004-0022-2.
  8. Erdem H, Kiliç S, Pahsa A, Besirbellioglu BA. Gram-negative bacterial resistance to cephalosporins in community-acquired infections in Turkey. J Chemother 2005; 17: 61–5.
  9. Ulcay A, Can M, et al. Saccharomyces boulardii and infection due to Giardia lamblia. Scand J Infect Dis 2006; 38: 479–81.
  10. Toker MI, Erdem H, Erdogan H, et al. The Effects of Topical Ketorolac and Indomethacin on Measles Conjunctivitis: Randomized Controlled Trial. Am J Ophthalmol 2006; 141: :902–905.
  11. Ormeci N, Kir M, Coban S, et al. The usefulness of endoscopic retrograde cholangiopancreatography and 99m Tc-labeled albumin macroaggregates in diagnosing hydatid disease fistulae. Dig Dis Sci 2007; 52: 1410–4.
  12. Ormeci N, Idilman R, Akyar S, et al. Hydatid cysts in muscle: a modified percutaneous treatment approach. Int J Infect Dis 2007; 11: 204–8.
  13. Kucukardali Y, Oncul O, Cavuslu S, et al. The spectrum of diseases causing fever of unknown origin in Turkey: a multicenter study. Int J Infect Dis 2008; 12: 71–9.
  14. Gul HC, Erdem H, Gorenek L, et al. Management of neurobrocellosis: An assessment of 11 cases. Intern Med 2008; 47: 995–1001.
  15. Coskun O, Gul HC, Mert G, et al. Brucellar Epididymo-Orchitis : A Retrospective Study. Trak Univ Tip Fak Derg 2009; 26: 1–6.
  16. 16       Erdem H, Kilic S, Coskun O, et al. Community-acquired acute bacterial meningitis in the elderly in Turkey. Clin Microbiol Infect 2010; 16: 1223–9.
  17. Coskun O, Sener K, Kilic S, et al. Stress-related Epstein-Barr virus reactivation. Clin Exp Med 2010; 10: 15–20.
  18. Ormeci N, Akbas F, Erden E, et al. Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months. Hepatogastroenterology 2011; 58: 1648–53.
  19. Erdem H, Tekin-Koruk S, Koruk I, et al. Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needs. Ann Clin Microbiol Antimicrob 2011; 10. DOI:10.1186/1476-0711-10-38.
  20. Erdem H, Tetik A, Arun O, Besirbellioglu BA, Coskun O, Eyigun CP. War and infection in the pre-antibiotic era: The Third Ottoman Army in 1915. Scand J Infect Dis 2011; 43: 690–5.
  21. Tekin-Koruk S, Erdem H, Koruk I, et al. Management of Brucella endocarditis: Results of the Gulhane study. Int J Antimicrob Agents 2012; 40: 145–50.
  22. Erdem H, Ulu-Kilic A, Kilic S, et al. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: Results of the Istanbul study. Antimicrob Agents Chemother 2012; 56: 1523–8.
  23. Erdem H, Kurtaran B, Arun O, et al. The place and the efficacy of infectious disease consultations in the hospitals. Infect Dis Clin Pract 2012; 20: 131–6.
  24. Palabıyıkoğlu M, Ormeci N, Ekiz F, et al. Amantadine in non-responder patients with chronic hepatitis C: a randomized prospective study. Hepatogastroenterology 2012; 59: 1911–4.
  25. Coskun O, Ozturk M, Erdem H, et al. Can chitotriosidase be a surrogate marker for invasive fungal disease? J Mycol Med 2012; 22: 256–60.
  26. Erdem H, Ozturk-Engin D, Tuna N, Kurtaran B, Parlak E. Infectious diseases departments and patients in the University Hospitals in Turkey. J Infect Dis Ther 2013; 1: 22–7.
  27. Yazicioǧlu-Moçin Ö, Karakurt Z, Aksoy F, et al. Bronchoscopy as an indicator of tracheobronchial fungal infection in non-neutropenic intensive-care unit patients. Clin Microbiol Infect 2013; 19: E136–E141.
  28. Erdem H, Dizbay M, Karabey S, et al. Withdrawal of Staphylococcus aureus from intensive care units in Turkey. Am J Infect Control 2013; 41: 1053–8.
  29. Erdem H, Turkan H, Cilli A, et al. Mortality indicators in community-acquired pneumonia requiring intensive care in Turkey. Int J Infect Dis 2013; 17: e768–72.
  30. Erdem H, Kilic S, Sener B, et al. Diagnosis of chronic brucellar meningitis and meningoencephalitis: The results of the Istanbul-2 study. Clin Microbiol Infect 2013; 19: E80–6.
  31. Cilli A, Erdem H, Karakurt Z, et al. Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: Risk factors for mortality. J Crit Care 2013; 28: 975–979.
  32. Avci IY, Eyigün CP, Günal E, et al. Demonstration of mutations conferring resistance to lamivudine in liver tissue of chronic hepatitis B patients under lamivudine therapy. Turkish J Med Sci 2013; 43: 199–202.
  33. Ergunay K, Gunay F, Oter K, et al. Arboviral surveillance of field-collected mosquitoes reveals circulation of west Nile virus lineage 1 strains in Eastern Thrace, Turkey. Vector-Borne Zoonotic Dis 2013; 13: 744–52.
  34. Oncul O, Oksuz S, Acar A, et al. Nosocomial infection characteristics in a burn intensive care unit: Analysis of an eleven-year active surveillance. Burns 2014; 40: 835–41.
  35. Date R, Date R, Date A, et al. Emergence and Coinfections of West Nile virus and Toscana Virus in Eastern Thrace, Turkey. 2014; 20: 319–25.
  36. Budak S, Oncul O, Aktas Z, et al. The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors. Southeast Asian J Trop Med Public Health 2014; 45: 113–22.
  37. Erdem H, Ozturk-Engin D, Elaldi N, et al. The microbiological diagnosis of tuberculous meningitis: Results of Haydarpasa-1 study. Clin Microbiol Infect 2014; 20: O847–O853.
  38. Erdem H, Stahl JP, Inan A, et al. The features of infectious diseases departments and anti-infective practices in France and Turkey: A cross-sectional study. Eur J Clin Microbiol Infect Dis 2014; 33: 1591–9.
  39. Erdem H, Inan A, Altindis S, et al. Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran – A prospective multicenter point prevalence study. J Infect 2014; 68: 131–40.
  40. Erdem H, Elaldi N, Öztoprak N, et al. Mortality indicators in pneumococcal meningitis: Therapeutic implications. Int J Infect Dis 2014; 19: 13–9.
  41. Erdem H, Elaldi N, Ak O, et al. Genitourinary brucellosis: Results of a multicentric study. Clin Microbiol Infect 2014; 20: O847–O853.
  42. Ozturk-Engin D, Erdem H, Gencer S, et al. Liver involvement in patients with brucellosis: Results of the Marmara study. Eur J Clin Microbiol Infect Dis 2014; 33: 1253–62.
  43. Erdem H, Ozturk-Engin D, Yesilyurt M, et al. Evaluation of tularaemia courses: A multicentre study from Turkey. Clin Microbiol Infect 2014; 20: O1042–O1051.
  44. Ulu-Kilic A, Karakas A, Erdem H, et al. Update on treatment options for spinal brucellosis. Clin Microbiol Infect 2014; 20: O75–O82.
  45. Erdem H, Kocak-Tufan Z, Yilmaz O, et al. The interrelations of radiologic findings and mechanical ventilation in community acquired pneumonia patients admitted to the intensive care unit: A multicentre retrospective study. Ann Clin Microbiol Antimicrob 2014; 13. DOI:10.1186/1476-0711-13-5.
  46. Erdem H, Inan A, Elaldi N, et al. Respiratory system involvement in brucellosis: The results of the Kardelen Study. Chest 2014; 145: 87–94.
  47. Karagoz E, Ulcay A, Tanoglu A, et al. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients. Eur J Gastroenterol Hepatol 2014; 26: 1320–4.
  48. Erdem H, Senbayrak S, Gencer S, et al. Tuberculous and brucellosis meningitis differential diagnosis. Travel Med Infect Dis 2015; 13: 185–91.
  49. Erdem H, Ozturk-Engin D, Tireli H, et al. Hamsi scoring in the prediction of unfavorable outcomes from tuberculous meningitis: results of Haydarpasa-II study. J Neurol 2015; 262: 890–8.
  50. Erdem H, Elaldi N, Batirel A, et al. Comparison of brucellar and tuberculous spondylodiscitis patients: Results of the multicenter ‘backbone-1 Study’. Spine J 2015; 15: 2509–2517 C.
  51. Senbayrak S, Ozkutuk N, Erdem H, et al. Antituberculosis drug resistance patterns in adults with tuberculous meningitis: Results of haydarpasa-iv study. Ann Clin Microbiol Antimicrob 2015; 14: 1–6.
  52. Erdem H, Cag Y, Ozturk-Engin D, et al. Results of a Multinational Study Suggest the Need for Rapid Diagnosis and Early Antiviral Treatment at the Onset of Herpetic Meningoencephalitis. Antimicrob Agents Chemother 2015; 59: 3084–9.
  53. Batirel A, Erdem H, Sengoz G, et al. The course of spinal tuberculosis (Pott disease): Results of the multinational, multicentre Backbone-2 study. Clin Microbiol Infect 2015; 21: 1008.e9-1008.e18.
  54. Karagöz E, Tanoğlu A, Ülçay A, et al. Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 2016; 28: 744–8.
  55. Karacaer Z, Cakir B, Erdem H, et al. Quality of life and related factors among chronic hepatitis B-infected patients: A multi-center study, Turkey. Health Qual Life Outcomes 2016; 14: 153.
  56. Cag Y, Ozturk-Engin D, Gencer S, et al. Hydrocephalus and vasculitis delay therapeutic responses in tuberculous meninigitis: Results of Haydarpasa-III study. Neurol India 2016; 64: 896‑905.
  57. Cag Y, Erdem H, Leib S, et al. Managing atypical and typical herpetic central nervous system infections: results of a multinational study. Clin Microbiol Infect 2016; 22: 568.e9–568.e17.
  58. Erdem H, Senbayrak S, Meriç K, et al. Cranial imaging findings in neurobrucellosis: results of Istanbul-3 study. Infection 2016; 44: 623–31.
  59. Erdem H, Ak O, Elaldi N, et al. Infections in travellers returning to Turkey from the Arabian peninsula: a retrospective cross-sectional multicenter study. Eur J Clin Microbiol Infect Dis 2016; 35: 903–10.
  60. Eruz ED, Yalci A, Ozden E, et al. Risk factors for infection development after transrectal prostate biopsy and the role of resistant bacteria in colonic flora. J Infect Dev Ctries 2017; 11: 188–91.
  61. Turktan M, Ak O, Erdem H, et al. Community acquired infections among refugees leading to Intensive Care Unit admissions in Turkey. Int J Infect Dis 2017; 58: 111–4.
  62. Erdem H, Inan A, Guven E, et al. The burden and epidemiology of community-acquired central nervous system infections: a multinational study. Eur J Clin Microbiol Infect Dis 2017; 36: 1595–611.
  63. Tosun S, Batirel A, Oluk AI, et al. Tetanus in adults: results of the multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis 2017; 36: 1455–62.
  64. Karagoz E, Tanoglu A, Turhan V, et al. Use of quantitative hepatitis B surface antigen levels in the follow-up of HBV-Infected patients with Genotype D. Med Sci | Int Med J 2018; 7: 515–23.
  65. Sally Hargreaves, Nellums LB, Ravensbergen SJ, et al. Divergent approaches in the vaccination of recently arrived migrants to Europe: a survey of national experts from 32 countries. Euro Surveill 2018; 23: 1700772.
  66. Hakyemez IN, Erdem H, Beraud G, et al. Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter Infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study. Eur J Clin Microbiol Infect Dis 2018; 37: 1231–40.
  67. Ozturk-Engin D, Erdem H, Hasbun R, et al. Predictors of unfavorable outcome in neurosyphilis : Multicenter ID-IRI Study. 2019;38(1):125-134.
  68. Alp E, Cookson B, Erdem H, et al. Infection control bundles in intensive care: an international cross-sectional survey in low- and middle-income countries. J Hosp Infect 2019; 101: 248–56.
  69. Inan A, Erdem H, Elaldi N, et al. Brucellosis in pregnancy: results of multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis 2019; 38: 1261–8.
  70. Ravensbergen SJ, Nellums LB, Hargreaves S, Stienstra Y, Friedland JS. National approaches to the vaccination of recently arrived migrants in Europe: A comparative policy analysis across 32 European countries. Travel Med Infect Dis 2019; 27: 33–8.
  71. Erdem H, Puca E, Ruch Y, Santos L, Ghanem-zoubi N, Argemi X. Portraying infective endocarditis : results of multinational ID-IRI study. Eur J Clin Microbiol Infect Dis 2019; 38: 1753–63.
  72. Rosenthal VD, Bat-Erdene I, Gupta D, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module. Am J Infect Control 2020; 48: 423–32.
  73. Erdem H, Cag Y, Gencer S, et al. Treatment of ventilator-associated pneumonia (VAP) caused by Acinetobacter: results of prospective and multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis 2020; 39: 45–52.
  74. Popescu CP, Florescu SA, Hasbun R, et al. Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection – Result of a multinational ID-IRI study. J Clin Virol 2020; 122: 104213.
  75. Diktas H, Uysal S, Erdem H, et al. A novel ID-IRI score : development and internal validation of the multivariable community-acquired sepsis clinical risk prediction model. Eur J Clin Microbiol Infect Dis 2020; 39: 689–701.
  76. Tanoglu A, Erdem H, Friedland JS, et al. Clinicopathological profile of gastrointestinal tuberculosis: a multinational ID-IRI study. Eur J Clin Microbiol Infect Dis 2020; 39: 493–500
  77. Beovic B, Ferreira-Coimbra F, Nadrah K, et al. Antibiotic use in patients with Coronavirus disease 2019 (COVID-19): A snapshot ID-IRI survey” Journal of Antimicrobial Chemotherapy. (In Press)

REVIEW PAPERS PUBLISHED IN INTERNATIONAL JOURNAL

  1. Erdem H, Pahsa A. Antibiotic resistance in pathogenic Streptococcus pneumoniae isolates in Turkey. J Chemother 2005; 17: 25–30.
  2. Oncu S, Erdem H, Pahsa A. Therapeutic options for pneumococcal pneumonia in Turkey. Clin Ther 2005; 27: 674–83.
  3. Ormeci N, Coban S, Palabiyikoglu M, et al. A modified percutaneous treatment for hydatid disease: The Ormeci method. 2006.
  4. Erdem H, Oncul O. A review of the current place of glycopeptides in Turkish medical practice. Curr Ther Res – Clin Exp 2007; 68: 49–66.
  5. Gul HC, Erdem H, Bek S. Overview of neurobrucellosis: a pooled analysis of 187 cases. Int J Infect Dis 2009; 13: e339–43.
  6. Coşkun O, Erdem H, Avcı A. Management of community-acquired acute bacterial cystitis in Turkey. Turkish J Med Sci 2011; 41: 149–57.
  7. Ormeci N, Erdem H. Basic answers to complicated questions for the course of chronic hepatitis C treatment. Expert Rev Gastroenterol Hepatol 2012; 6: 371–82.
  8. Erdem H, Akova M. Leading infectious diseases problems in Turkey. Clin Microbiol Infect 2012; 18: 1056–67.
  9. Erdem H, Unal S. New global viral threats. Saudi Med J 2015; 36: 393–8.
  10. Alp E, Erdem H, Rello J. Management of septic shock and severe infections in migrants and returning travelers requiring critical care. Eur J Clin Microbiol Infect Dis 2016; 35: 527–33.

 

OTHER PAPERS (SHORT COMMUNICATION, TECHNICAL NOTE, LETTER TO THE EDITOR, CASE PRESENTATION) PUBLISHED IN INTERNATIONAL JOURNALS

  1. Erdem H, Oncu S, Pahsa A. Prevalence of Hepatitis B virus infection in young Turkish male population. Trop Doct 2005; 35: 192.
  2. Duztas O, Erdem H, Pahsa A, Emekdas G, Avci A. Epidemiology of corynebacterial urinary infections. Int J Infect Dis 2006; 10: 264.
  3. Erdem H, Aksoy B, Kilic S, et al. Profiles of biochemical parameters in central nervous system fluid during the therapeutic courses of adult Mycobacterium tuberculosis meningitis. Scand J Infect Dis 2006; 38: 710–2.
  4. Komurcu M, Botanlioglu H, Erdem H, Albay A. Delayed and misdiagnosis of wrist tuberculosis. Int J Infect Dis 2006; 10: 337.
  5. Coskun O, Erdem H, Besirbellioglu BA, Eyigun CP. Distribution of hepatitis C virus infection in the male Turkish population. Int J Infect Dis 2006; 10: 481–7.
  6. Erdem H, Pahsa A, Oncu S. Antimicrobial therapy in pneumococcal meningitis: an epidemiological assessment from Turkey. Int J Infect Dis 2006; 10: 262–3.
  7. Erdem H, Cekmez F, Pahsa A. Giardiasis in Sivas, Turkey. 2006; 36: 64.
  8. Coskun O, Erdem H, Gul HC, Eyigun CP. Changes in hepatitis A prevalence rates between 1998 and 2007 in Eskisehir, Turkey. Int J Infect Dis 2008; 12: e141.
  9. Gul HC, Mert G, Erdem H, et al. Brucellosis associated with thrombophilebitis: A case report. Am J Case Rep 2008; 9: 31–3.
  10. Erdem H. An update on invasive pneumococcal antibiotic resistance in Turkey, 2008. J Chemother 2008; 20: 697–701.
  11. Senses Z, Yokusoglu M, Oz BS, et al. A rare pathogen causing endocarditis: Streptococcus constellatus. Anatol J Cardiol 2008; 8: 315–6.
  12. Ozkan H, Dogramaci Y, Kose O, Esen E, Erdem H, Komurcu M. Primary hydatid disease of the humerus. Ann Acad Med Singapore 2008; 37: 440–1.
  13. Coskun O, Gul C, Erdem H, Bedir O, Eyigun CP. Prevalence of HIV and syphilis among Turkish blood donors. Ann Saudi Med 2008; 28: 470.
  14. Coskun O, Erdem H, Gul HC, Besirbellioglu BA, Sener K, Eyigun CP. Meningoencephalitis associated with human parvovirus B19. Clin Microbiol Infect 2008; 14: 1188–90.
  15. Erdem H, Sener B. Pneumococcal seroepidemiology in Turkey: Implications for vaccine coverage. Vaccine 2008; 26. DOI:10.1016/j.vaccine.2007.12.036.
  16. Erdem H, Sener B. Pneumococcal seroepidemiology in Turkey. Vaccine 2009; 27: 629–630.
  17. Hatipoǧlu M, Ulçay A, Turhan V, et al. [Two imported and relapsed of Plasmodium vivax malaria cases and primaquine prophylaxis]. Acta Parasitol Turc 2014; 38: 120–3.
  18. Cilli A, Karakurt Z, Erdem H. Comment to the Letter to the Editor. J Crit Care 2014; 29: 463–4.
  19. Ulcay A, Karaahmetoglu G, Turhan V, et al. [The management of therapeutic failure in a falciparum malaria patient under oral arthemether-lumefantrine therapy]. Acta Parasitol Turc 2014; 38: 61–7.
  20. Erdem H, Cag Y. Re. ‘Managing atypical and typical herpetic central nervous system infections: results of a multinational study’’ Author’s reply’. Clin Microbiol Infect 2017; 23: 420.
  21. Erdem H, Cag Y, Senbayrak S, et al. Other Foci of Infections in Community Acquired Central Nervous System Infections. J Meningitis 2017; 1: 8–10.
  22. Erdem H, Ozturk-Engin D, Cag Y, et al. Central nervous system infections in the absence of cerebrospinal fluid pleocytosis. Int J Infect Dis 2017; 65: 107–9.
  23. Poulakou G, Matthaiou DK, Bassetti M, et al. Salvage treatment for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal. Intensive Care Med 2017; 43: 1164–6.
  24. Kilicoglu G, Ozturk-Engin D, Tireli H, et al. Radiological data in microbiologically confirmed central nervous system tuberculosis. Clin Microbiol Infect 2018; 24: 1109–10.
  25. Sah R, Khadka S, Shrestha GS, et al. Detection of Pan drug resistance OXA-48 producing Providencia in an ICU patient for the first time in Nepal. Antimicrob Resist Infect Control 2019; 8: 1–7.
  26. Ankarali H, Ankarali S, Caskurlu H, et al. A Statistical Modeling of the Course of COVID-19 (SARS-CoV-2) Outbreak: A Comparative Analysis. Asia-Pacific J Public Heal 2020. DOI:10.1177/1010539520928180.

 

ORIGINAL ARTICLES PUBLISHED IN LOCAL JOURNALS

  1. Cesur S, Şengül A, Kurtoğlu Y, Kalpakçı Y, Özel S.A., Bilgetürk A, Erdem H, Aslan T, Kınıklı S, Eyigün C.P, Bıyıklı Z. Prognostic value of cytokines (TNF-?, IL-10, Leptin) and C-reactive protein serum levels in adult patients with nosocomial sepsis. J Microbiol Infect Dis 2011; 1(3):101-109
  2. Pahsa A, Avci A, Erdem H, Kılıç S, Tahmaz L, Dayanç M. Çocuk yaş grubu hastalarda toplum kökenli üriner enfeksiyonlarda güncel tedavi yaklaşımları ve iklim ölçütleri ile ilişkisi. Türk Üroloji Dergisi 2007: 33(2): 172-80
  3. Gul HC, Coşkun O, Turhan V, Beşirbellioğlu B, Bilgetürk A, Erdem H, Avcı İY, Gorenek L, Eyigun CP. Bruselloz: 140 olgunun geriye dönük olarak irdelenmesi. Türk Silahlı Kuvvetleri Koruyucu Hekimlik Bülteni. 2007: 6(4):249-252
  4. Erdem H, Avcı A, Pahsa A. Toplum kökenli üropatojenik E.coli suşlarında antibakteriyel direnç. Ankem Dergisi 2004; 18(1):40-44.
  5. Erdem H, Çetin M, Timuroğlu T, Çetin A, Yanar O, Öncül O, Cavuşlu S, Pahsa A. Vaginal Yeasts: Identification and Antifungal Resistance. GORM Gynecology Obstetrics & Reproductive Medicine. 2003 ;9:29-32.
  6. Yıldırım A, Erdem H, Kunt T, Canbay E. Kronik sinüzitte bakteriyoloji ve antibiyotik duyarlılılğı. KBB Forum 2003:2(4): 65-67.
  7. Erdem H, Nagıyev A, Pahsa A. Sivas bölgesinde etken olarak izole edilen pnömokoklarda beta laktam dışı antibiyotik direnci. Ankem Dergisi 2003; 17(4): 442.
  8. Selek MB, Kula-Atik T, Bektöre B, Baylan O, Özyurt M, Erdem H. İmmün sistemi baskılanmış bir hastada Corynebacterium striatum’un etken olduğu pnömoni ve bakteriyemi olgusu. Gülhane Tıp Dergisi, 2015;57: 193-195
  9. Erdem H, Beşirbellioğlu B.A., Öz B, Tetik A, Batur Ş, Erdem A, Savaşçı Ü, Özbay G. İspanyol Gribi ile İlgili Bakteriyolog Osman Şerafeddin’in 1923 Yılında Yayınlanan Makalesi. Mediterranean J Infect Microb Antimicrob 2012;1:9
  10. Gül HC, Turhan V, Coskun O, Erdem H, Avcı İY, Beşirbellioğlu BA, Eyigün CP. Performance of the accelerated Hepatitis B vaccination performed with three different recombinant vaccines in healthy soldiers. The Anatolian Journal of Clinical Investigation 2007;1(4):249-254
  11. Küçükardalı Y, Öncül O, Kunter E, et al. Fever of Unknown Origin – Are There Predictors of Outcome: A Multicenter Study. The Anatolian Journal of Clinical Investigation 2007;1(2):111-117
  12. Nağıyey A, Erdem H, Eyigun CP, Pahsa A. Erişkinlerde gözlenen 51 difteri olgusunun irdelenmesi. Klimik Dergisi 2004: 17(3): 196-99.
  13. Avcı A, Özgök A, Erdem H, Sağlam M, Bedir S, Kilciler M,Özgök Y. Transrektal ultrasonografi eşliğinde yapılan 12 kor prostat biyopsisinde komplikasyonlar. Üroloji Bülteni. 2004: 15;153-58.
  14. Erdem H, Pahsa A. Askeri bir birlikte kızamık salgını: Altyapıya ilişkin bir irdeleme. İnfeksiyon Dergisi 2004; 18 (3): 307-310.
  15. Erdem H, Kılıç S, Pahsa A. Amebiyaz: Epidemiyolojik bir inceleme. İnfeksiyon Dergisi 2004; 18(1): 73-77.
  16. Erdem H, Polat Z, Kılıç S, Pahsa A. Klindamisin ile ilişkili diyare ve Saccharomyces boulardii. Klimik Dergisi 2003; 16(1) 31-33.
  17. Erdem H, Pahsa A, Örmeci N. Askerlerde HCV İnfeksiyonlarına Yönelik bir irdeleme. Türkiye Klinikleri Gastroenterohepatoloji 2003:14:173-76.
  18. Erdem H, Öncül O, Çavuşlu Ş, Pahsa A. Sivas Bölgesinde hastalık etkeni pnömokoklarda direnç. Klimik Dergisi 2002; 15(2): 46-48.
  19. Kibar Y, Erdem H, Pahsa A, Özgüven V, Erduran D. Gülhane Askeri Tıp Akademisi’nde nozokomiyal infeksiyon trendi ve üroloji kliniginin bu trend içerisindeki yeri. Üroloji Bülteni 2002; 13(2): 97-101.
  20. Özsoy MF, Öncül O, Pahsa A, Erdem H, Emektaş G. Etil alkol povidon iyot ve benzalkonyum klorürün Pseudomonas aeruginosa suşlarına karşı etkinliği. Klimik Dergisi 2001: 14(1): 30-32.
  21. Pahsa A, Özsoy MF, Öncül O, Erdem H, Yenen OŞ. GATA Haydarpaşa Eğitim Hastanesi’nde 1993-1998 yılları arasında incelenen kan kültürlerinin irdelenmesi. Hastane İnfeksiyonları Dergisi 2000; 4(1): 51-57.
  22. Öncül O, Özsoy MF, Pahsa A, Erdem H. Salmonelloz: 71 Olgunun Değerlendirilmesi. Türk Mikrobiyoloji Cemiyeti Dergisi. 1999; 29(3-4): 127-32

 

REVIEW PAPERS PUBLISHED IN LOCAL JOURNALS

  1. Mert G, Erdem H. Sefdinir ve Klinik Kullanımı. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi 2011; 16 (EK 3):1-8.
  2. Erdem H. Türkiye^de epidemiyolojik veriler ışığında sulbaktam kullanım alanları. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi 2010; 15 (EK 4):5-12
  3. Özlü T, Bülbül Y, Alataş F, et al. Türk Toraks Derneği erişkinlerde toplumda gelişen pnömoni tanı ve tedavi uzlaşı raporu. Türk Toraks Dergisi Cilt 10 o Ek 9 o Haziran 2009
  4. Erdem H, Unal S. Antibiotic Choices in an Outpatient Community with Acquired Respiratory Tract Infections in Turkey. Tur Toraks Der 2009;10:86-90
  5. Erdem H, Artuk C, Coşkun Ö. Infectious Etiology of Hospitalized Community-Acquired Pneumonia Patients in Turkey. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi 2009: 14(2): 53-57
  6. Erdem H, Unal S. Türkiye’de bağışıklığı yeterli erişkinlerde toplum kökenli pnömoni tedavisi. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi 2007: 12 (2);67-79
  7. Erdem H, Nagıyev A, Pahsa A. Sivas bölgesinde etken olarak izole edilen pnömokoklarda beta laktam dışı antibiyotik direnci. Ankem Dergisi 2003; 17(4): 442.
  8. Selek MB, Kula-Atik T, Bektöre B, Baylan O, Özyurt M, Erdem H. İmmün sistemi baskılanmış bir hastada Corynebacterium striatum’un etken olduğu pnömoni ve bakteriyemi olgusu. Gülhane Tıp Dergisi, 2015;57: 193-195
  9. Budak S, Aktaş Z, Erdem H. Enterik Gram-Negatif Bakterilerde Laboratuvardan Kliniğe Karbapenemazlar. Med J Infect Microb Antimicrob. 2012;1:1
  10. Erdem H, Turkiye’deki yaşlılarda akut bakteriyel menenjitte ampirik antibiyotik kulanımı. Akad Geriatri 2009; 1:107-112.
  11. Erdem H. Fülminan karaciğer yetmezliği. Klimik Dergisi 2006: 19(3):104-9.
  12. Kibar Y, Erdem H, Akay O, Pahsa A, Özgok Y. İndinavir kullanımına bağlı bir ürolityaz olgusu. İnfeksiyon Dergisi 2005:19(4):477-79
  13. Erdem H, Bakır M, Dökmetaş İ, Pahsa A. Bacillus anthracis ve biyolojik saldırı. İnfeksiyon Dergisi 2004:18(3)381-92.
  14. Pahsa A, Erdem H. ESBL’lerin kontrol önlemleri ve korunma. Yeni ve Yeniden Gündeme Gelen İnfeksiyonlar Dergisi. 2004; 35-40.
  15. Erdem H, Pahsa A. Değişen Dünya ve İnfeksiyon Hastalıkları. Klimik Dergisi 2003: 16(1): 8-10.
  16. Erdem H, Pahsa A. Yeni Bir pandemi mi? Batı nil virus infeksiyonu. İnfeksiyon Dergisi 2003;17(2):245-249.
  17. Erdem H, Bakır M. Toplumdan edinilmiş patojenlerde antibiyotik ve direnç ilişkisi. Klimik Dergisi 2002; 15(1): 8-11.
  18. Erdem H, Pahsa A. Biyolojik silah saldırılarına yönelik ulusal ve bölgesel yaklaşımlar. İnfeksiyon Dergisi 2002; 16(EK 3).
  19. Pahsa A, Özsoy MF, Öncül O, Erdem H, Elbüken E. İnfeksiyon Hastalıklarında Hiperbarik Oksijen Tedavisinin yeri. Sendrom Dergisi 2001; 84-88.
  20. Erdem H, Özgün A, Pahsa A. Artan infeksiyöz bir tehdit: Biyosilahlar. Sendrom Dergisi 2001; 13(12): 106-110.

 

BEING AN AUTHOR IN NATIONAL BOOKS

  • Erdem H. Hastane florasında antibiyoıtik direnci In: Hastane infeksiyonları Kitabında (Doğancı L, Pahsa A eds.) GATA Basımevi, 2.baskı, Ankara p: 835-45, 2005
  • Erdem H, Pahsa A. Hepatit C Virüsü Epidemiyolojisi. In: Ceptıp kitabında (Balık İ, ed). Bilimsel Tıp Yayınevi, Ankara, p:26-35, 2005.
  • Pahsa A, Erdem H. Difteri ve diğer Coorynebacterium infeksiyonlari. İç Hastalıkları Kitabında (Aktaş F ed) Nobel Tıp Kitabevi, Bölüm 25, p:1-6, 2007
  • Erdem H. Karaciğer iğne biyopsisi. Viral Hepaitit 2007 kitabında (Tabak F, Balık İ, Tekeli E, eds) 2007, p: 368-75,2007
  • Erdem H. Grip Tedavisinde Kullanılan Antiviral İlaçlar. Leblebicioğlu H, Usluer G, Ulusoy S eds. In: Güncel Bilgiler Işığında Antibiyotikler.  Bilimsel Tıp Kitabevi, p: 593-606. 2008
  • Erdem H. Alt Solunum Yolu İnfeksiyonu Etkenleri ve Direnç. Alt Solunum Yolu Enfeksiyonları Kitabında. Arman D ed. Bilimsel Tıp Kitabevi, p: 9-23, 2008.
  • Erdem H. Solunum Yolu İnfeksiyonu Etkenleri ve Direnç. Güncel Bilgiler Işığında Solunum Yolu Enfeksiyonları Kitabında. Arman D ed. Bilimsel Tıp Kitabevi, p: 9-20, 2008.
  • Erdem H. Ciddi İnfeksiyonlar ve Beta-Laktam/ Beta-Laktamaz İnhibitör Kombinasyonlarının Klinik Kullanımları.Ciddi İnfeksiyonların Tedavisinde Beta-Laktam/ Beta-Laktamaz İnhibitör Kombinasyonları Kitabında. Ulusoy S ed. Bilimsel Tıp Kitabevi, p: 25-40, 2008.
  • Coşkun O, Erdem H. Akut Viral Hepatitler, Ulusoy S, Leblebicioğlu H eds In: Önemli ve Sorunlu Viral İnfeksiyonlar kitabı, Bilimsel Tip Yayinevi p: 37-50, 2008.
  • Erdem H. Karaciğer İğne Biyopsisi. Köksal I, Leblebicioğlu H eds. In: Kronik Hepatitlerin Tanı ve Tedavisinde Güncel Yaklaşımlar, Bilimsel Tıp Yayınevi p: 54-62, 2009.
  • Erdem H, Eyigün CP. Hepatit C infeksiyonunun patogenezi ve doğal seyri. Köksal I, Leblebicioğlu H eds. In: Kronik Hepatitlerin Tanı ve Tedavisinde Güncel Yaklaşımlar, Bilimsel Tıp Yayınevi p: 40-53, 2009.
  • Erdem H. Kronik Hepatit C’de Tedavi. Arman D, Leblebicioğlu H eds. In. Kronik Hepatit C Tedavisi ve Tedaviye Bağlı İstenmeyen Etkilerin yönetimi. Bilimsel Tıp Yayınevi p: 23-32, 2009
  • Erdem H. Solunumsal patojenler. Özlü T ed. In: Solunum sistemi ve hastalıklari temel başvuru kitabı. İstanbul Tıp Yayınevi, p:775-91, 2010
  • Erdem H. Antiviral İlaçlar. In: Kurt H, Gündeş S, Geyik M.F., eds. Enfeksiyon hastalıkları: Nobel Tıp Kitabevleri 2013; 121-124.
  • Doğan-Çelik A, Erdem H. Gebelik ve Ateş. Arman D ed. In: Gebelik ve İnfeksiyon. Bilimsel Tıp Yayınevi p: 565-73, 2013. ISBN: 978-605-4488-26-1.
  • Erdem H. Nazokomiyal pnömoni. In: Klinik konular ve ilgili cerrahi teknik atlası. (http://www.turkcer.org.tr/).

 

SCIENTIFIC TRANSLATIONS

  1. Akut Bronşit. Manual of Clinical Problems in Infectious Disease kitabından. Nelson M. Gantz, Richard B. Brown, Steven L. Berk, James W. Myers eds. Lippincott Williams & Wilkins. Orjinal ISBN: 0-7817-5929-3, Çeviri ISBN: 978-975-277-379-0
  2. Antibiyotik dirençli pnömokok. Manual of Clinical Problems in Infectious Disease kitabından. Nelson M. Gantz, Richard B. Brown, Steven L. Berk, James W. Myers eds. Lippincott Williams & Wilkins. Orjinal ISBN: 0-7817-5929-3, Çeviri ISBN: 978-975-277-379-0
  3. Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011 Feb 15;52(4):e56-93.

 

NATIONAL AWARDS

  • Erdem H. Inan A, Elaldi N, solunumsal bruselloz çalışma grubu. Brusellozda solunum sistemi tutulumu: Kardelen çalışması sonuçları. EKMUD 2013 Bilimsel Platformu. Birincilik ödülü. (20-24 Mart 2013)
  • Erdem H. Ozturk Engin D, Vahaboğlu H ve çalışma grubu. Tüberküloz menenjitli hastalarda olumsuz akıbeti değerlendiren HAMSİ ölçeği: Haydarpaşa-2 çalışmasının sonuçları. 5 Türkiye EKMUD Kongresi 2014, Sözlü bildiri birincilik ödülü. (21-25 Mayıs 2014)

 

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s